#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.MedicalEntity|DCT|MedicalEntity
#T_RL=webanno.custom.TLINK|TLINK|BT_webanno.custom.MedicalEntity


#Text=10.05.2023:
#Text=Moderat effekt av behandling.
1-1	0-10	10.05.2023	_	_	_	_	
1-2	10-11	:	_	_	_	_	
1-3	12-19	Moderat	_	_	_	_	
1-4	20-26	effekt	_	_	_	_	
1-5	27-29	av	_	_	_	_	
1-6	30-40	behandling	_	_	_	_	
1-7	40-41	.	_	_	_	_	

#Text=Fortsatt tett nese og hodepine.
2-1	42-50	Fortsatt	_	_	_	_	
2-2	51-55	tett	OVERLAP[1]	CONDITION[1]	_	_	
2-3	56-60	nese	OVERLAP[1]	CONDITION[1]	_	_	
2-4	61-63	og	_	_	_	_	
2-5	64-72	hodepine	OVERLAP	CONDITION	_	_	
2-6	72-73	.	_	_	_	_	

#Text=Ny CT viser vedvarende slimhinnefortykkelse.
3-1	74-76	Ny	_	_	_	_	
3-2	77-79	CT	OVERLAP	TREATMENT	_	_	
3-3	80-85	viser	_	_	_	_	
3-4	86-96	vedvarende	OVERLAP[2]	CONDITION[2]	OVERLAP	3-2[0_2]	
3-5	97-117	slimhinnefortykkelse	OVERLAP[2]	CONDITION[2]	_	_	
3-6	117-118	.	_	_	_	_	

#Text=Planlegger FESS-operasjon.
4-1	119-129	Planlegger	_	_	_	_	
4-2	130-144	FESS-operasjon	AFTER	TREATMENT	_	_	
4-3	144-145	.	_	_	_	_	

#Text=Optimaliserer medisinsk behandling preoperativt.
5-1	146-159	Optimaliserer	_	_	_	_	
5-2	160-169	medisinsk	AFTER[3]	TREATMENT[3]	_	_	
5-3	170-180	behandling	AFTER[3]	TREATMENT[3]	_	_	
5-4	181-193	preoperativt	_	_	_	_	
5-5	193-194	.	_	_	_	_	
